Protein Expression of bax, bcl-2, and p53 in Patients with Non-Hodgkin's Gastric Lymphoma: Prognostic Significance
Protein Expression of bax, bcl-2, and p53 in Patients with Non-Hodgkin's Gastric Lymphoma: Prognostic Significance
复制标题
非霍奇金胃淋巴瘤患者中 bax、bcl-2 和 p53 的蛋白表达:预后意义
DOI:
--
复制
发表时间:
2000
影响因子:
2.6
通讯作者:
G. Androulakis
中科院分区:
文献类型:
--
作者:
G. Charalambous;I. Gomatos;M. Konstadoulakis;E. Messaris;A. Manouras;A. Apostolou;E. Leandros;M. Karayannis;G. Androulakis
Abstract. The biologic significance of bcl-2, bax, and p53 gene expression in patients with non-Hodgkin's gastric lymphoma is unknown. We examined the prognostic value of these genes in 36 patients with gastric lymphoma treated in our clinic between 1990 and 1995. Paraffin-embedded specimens from 36 patients who underwent primary resection of the stomach for gastric lymphoma were analyzed immunohistochemically for p53, bax, and bcl-2 gene expression. Expression of bax was seen in 24 of 36 patients (66.7%), p53 expression was found in 8 of 36 tumors (22.2%), and bcl-2 cytoplasmic staining was detected in 6 of 36 patients (16.7%). We performed a univariate analysis to examine the possible correlation between the expression of these genes and the survival of our patients. Expression of bax protein proved to be a statistically significant prognostic factor (p= 0.049). Protein expression of p53 and bcl-2 did not statistically correlate with survival. In the bcl-2-negative (−) patient group (30 patients), those who were bax-positive had a statistically significant better survival than those who were bax-negative (63.3% vs. 36.7%, p= 0.03). There was also a statistically significant correlation between p53 expression and the grade of the tumor (p= 0.0014). P53 protein expression increased along with the grade. Expression of bax is a significant prognostic factor in patients with gastric lymphoma. Its prognostic value increases significantly when studied in bcl-2-negative patients; but expression of bax failed to be an independent prognostic factor. Expression of bcl-2 and p53 has no prognostic significance. Expression of p53 seems to represent a marker for loss of differentiation.
登录
查看更多内容
DOI:
10.1200/jco.1990.8.2.266
发表时间:
1990
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
Maor,MH;Velasquez,WS;Fuller,LM;Silvermintz,KB
通讯作者:
Silvermintz,KB
影响因子:
56.9
作者:
TSUJIMOTO, Y;COSSMAN, J;CROCE, CM
通讯作者:
CROCE, CM
DOI:
10.1073/pnas.82.21.7439
发表时间:
1985-01-01
影响因子:
11.1
作者:
CLEARY, ML;SKLAR, J
通讯作者:
SKLAR, J
DOI:
--
发表时间:
1993
期刊:
The American journal of pathology
影响因子:
--
作者:
Cesarman,E;Inghirami,G;Chadburn,A;Knowles,DM
通讯作者:
Knowles,DM
影响因子:
56.9
作者:
HOLLSTEIN, M;SIDRANSKY, D;HARRIS, CC
通讯作者:
HARRIS, CC